Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Rev Colomb Psiquiatr ; 2023 Apr 14.
Article in Spanish | MEDLINE | ID: covidwho-2325259

ABSTRACT

Introduction: During the COVID-19 pandemic, different events arose worldwide, including the impact on the mental health of health personnel. Our main aim was to determine the association between sociodemographic, clinical, tobacco and alcohol abuse, and fear of COVID-19 variables with the presence of depressive symptoms in a healthcare facility, in Bogotá DC, in 2022. Materials and methods: Analytical cross-sectional study. Sociodemographic and clinical variables, alcohol and tobacco abuse, and fear of COVID-19 were explored. The presence and severity of depressive symptoms were evaluated with the PHQ-9 scale. Descriptive analysis and chi-square tests were performed. Statistically significant variables (P < .05) were entered into a logistic regression model with depressive symptoms as the dependent variable. Results: 597 people were included, 80% female. The median age was 34 years (Interquartile Range [IQR]: 28-41. The prevalence of depressive symptoms was 12.4% (95% CI: 9,74-15,05). The multivariate analysis showed that fear of COVID-19, tobacco use, age under 28, and middle socioeconomic status were the factors that best explained the presence of depressive symptoms. Conclusions: Two years after COVID-19 was declared a pandemic, the prevalence of depressive symptoms is 12.4%. It is necessary to carry out strategies to promote mental health in health professionals.

2.
Rev Colomb Psiquiatr ; 2023 Apr 14.
Article in Spanish | MEDLINE | ID: covidwho-2310169

ABSTRACT

Introduction: During the COVID-19 pandemic, different events arose worldwide, including the impact on the mental health of health personnel. Our main aim was to determine the association between sociodemographic, clinical, tobacco and alcohol abuse, and fear of COVID-19 variables with the presence of depressive symptoms in a healthcare facility, in Bogotá DC, in 2022. Materials and methods: Analytical cross-sectional study. Sociodemographic and clinical variables, alcohol and tobacco abuse, and fear of COVID-19 were explored. The presence and severity of depressive symptoms were evaluated with the PHQ-9 scale. Descriptive analysis and chi-square tests were performed. Statistically significant variables (P < .05) were entered into a logistic regression model with depressive symptoms as the dependent variable. Results: 597 people were included, 80% female. The median age was 34 years (Interquartile Range [IQR]: 28-41. The prevalence of depressive symptoms was 12.4% (95% CI: 9,74-15,05). The multivariate analysis showed that fear of COVID-19, tobacco use, age under 28, and middle socioeconomic status were the factors that best explained the presence of depressive symptoms. Conclusions: Two years after COVID-19 was declared a pandemic, the prevalence of depressive symptoms is 12.4%. It is necessary to carry out strategies to promote mental health in health professionals.

3.
Revista colombiana de psiquiatria ; 2023.
Article in Spanish | EuropePMC | ID: covidwho-2301037

ABSTRACT

Introducción: Con el advenimiento de la pandemia por COVID-19, surgieron diferentes acontecimientos a nivel mundial, entre ellos la afectación de la salud mental del personal sanitario. El objetivo de este estudio fue determinar la asociación entre variables sociodemográficas, clínicas, de consumo de tabaco y alcohol y miedo al COVID-19 con la aparición de síntomas de depresión en una Institución Prestadora de Servicios de Salud (IPS), en Bogotá DC, en 2022. Métodos: Estudio transversal analítico, se exploraron variables sociodemográficas, clínicas, consumo de alcohol, tabaco, miedo al COVID-19. La presencia y gravedad de los síntomas depresivos se evaluó con la escala PHQ-9, se realizó un análisis descriptivo de las variables independientes, se realizaron pruebas de chi cuadrado y se consideró un valor p<0.05 como estadísticamente significativo. Las variables que resultaron estadísticamente significativas fueron ingresadas a un modelo de regresión logística con "síntomas depresivos” como variable dependiente. Resultados: Se incluyeron 597 personas (80% mujeres), con una edad mediana de 34 años (RIC 28-41). La prevalencia de síntomas depresivos fue 12.4% (IC95%=9,74-15,05). El análisis multivariado mostró que los factores que mejor explicaron la presencia de síntomas depresivos fueron: miedo al COVID-19, consumo de tabaco, edad menor a 28 años, estrato socioeconómico medio. Conclusiones: A dos años de que el COVID-19 fuera declarado una pandemia, la prevalencia de síntomas depresivos es del 12.4%. Se requiere implementar estrategias en pro la salud mental de los profesionales sanitarios.

SELECTION OF CITATIONS
SEARCH DETAIL